XML 46 R36.htm IDEA: XBRL DOCUMENT v3.21.2

Acquisition of Quellis (Details) - USD ($) $ in Thousands			6 Months Ended
	Jun. 02, 2021	Jan. 28, 2021	Jun. 30, 2021
Common Stock
Acquisition of Quellis
Issuance of common stock upon acquisition of Quellis (in shares)			3,332,669
Quellis Biosciences, Inc
Acquisition of Quellis
Cost to acquire the assets		$ 170,681
Acquisition costs		$ 1,800
Quellis Biosciences, Inc | Common Stock
Acquisition of Quellis
Issuance of common stock upon acquisition of Quellis (in shares)		3,332,669
Series X redeemable convertible preferred stock
Acquisition of Quellis
Issuance of preferred stock upon acquisition of Quellis (in shares)			50,504
Number of shares of common stock into which each share of Series X Preferred Stock may be converted	1,000		1,000
Series X redeemable convertible preferred stock | Quellis Biosciences, Inc
Acquisition of Quellis
Issuance of preferred stock upon acquisition of Quellis (in shares)		50,504
Number of shares of common stock into which each share of Series X Preferred Stock may be converted		1,000

X

- Definition

Amount recognized as of the acquisition date for the identifiable assets acquired other than intangible assets in excess of (less than) the aggregate liabilities assumed other than deferred tax liabilities.

+ References

No definition available.

+ Details

Name:	catb_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherThanIntangibleAssetsAndDeferredTaxLiabilities
Namespace Prefix:	catb_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

X

- Definition

The number of shares of common stock into which each share of Series X Preferred Stock may be converted.

+ References

No definition available.

+ Details

Name:	catb_TemporaryEquityConversionBasis
Namespace Prefix:	catb_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of new shares classified as temporary equity issued in an acquisition during the period.

+ References

No definition available.

+ Details

Name:	catb_TemporaryEquityStockIssuedInAcquisitionSharesNewIssues
Namespace Prefix:	catb_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Definition

The capitalized costs incurred during the period (excluded from amortization) to purchase, lease or otherwise acquire an unproved property, including costs of lease bonuses and options to purchase or lease properties, the portion of costs applicable to minerals when land including mineral rights is purchased in fee, brokers' fees, recording fees, legal costs, and other costs incurred in acquiring properties.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 932
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-10(c)(7)(ii))
-URI http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 932
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-10(c)(3)(ii)(A))
-URI http://asc.fasb.org/extlink&oid=120398226&loc=d3e511914-122862

+ Details

Name:	us-gaap_AcquisitionCosts
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_BusinessAcquisitionLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Number of shares of stock issued during the period pursuant to acquisitions.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

+ Details

Name:	us-gaap_StockIssuedDuringPeriodSharesAcquisitions
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_BusinessAcquisitionAxis=catb_AgreementAndPlanOfMergerQuellisBiosciencesIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_StatementClassOfStockAxis=catb_SeriesXRedeemableConvertiblePreferredStockMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: